Skip to main content

Articles

Page 5 of 61

  1. This study aimed to investigate the association between the triglyceride–glucose (TyG) index and left ventricular global longitudinal strain (GLS) in patients with coronary heart disease and to examine the rol...

    Authors: Lin Na, Wenjing Cui, Xinqi Li, Jing Chang and Xin Xue
    Citation: Cardiovascular Diabetology 2023 22:321
  2. The Triglyceride-glucose (TyG) index, a novel indicator of insulin resistance, has been associated with mortality from coronary artery diseases, ischemic stroke, and heart failure. In recent years, much emphas...

    Authors: Jiaqi Chen, Kangxiang Wu, Yiying Lin, Mingyuan Huang and Shanghe Xie
    Citation: Cardiovascular Diabetology 2023 22:320
  3. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have proven cardiovascular benefits, are recommended in people with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Howeve...

    Authors: Xi Tan, Yuanjie Liang, Jigar R. Rajpura, Larisa Yedigarova, Josh Noone, Lin Xie, Silvio Inzucchi and Adam de Havenon
    Citation: Cardiovascular Diabetology 2023 22:319
  4. Diabetes mellitus (DM), heart failure (HF) and metabolic dysfunction associated steatotic liver disease (MASLD) are overlapping diseases of increasing prevalence. Because there are still high numbers of patien...

    Authors: Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, Mirela Hendel, Karolina Drożdż, Agata M. Wijata, Jakub Nalepa, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2023 22:318
  5. Diabetes mellitus (DM) is the most common metabolic disease worldwide and a major risk factor for adverse cardiovascular events, while the additive effects of DM on left ventricular (LV) deformation in the res...

    Authors: Yue Gao, Yi-Ning Jiang, Rui Shi, Ying-Kun Guo, Hua-Yan Xu, Chen-Yan Min, Zhi-Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2023 22:317
  6. Heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus (T2DM) are common and interrelated conditions, each with a significant burden of disease. HF and kidney disease progress through p...

    Authors: Robert J. Mentz, Stephen A. Brunton and Janani Rangaswami
    Citation: Cardiovascular Diabetology 2023 22:316
  7. The association of glycemic variability with severe consciousness disturbance and in-hospital all-cause mortality in critically ill patients with cerebrovascular disease (CVD) remains unclear, This study aimed...

    Authors: Weimin Cai, Yaling Li, Kun Guo, Xiao Wu, Chao Chen and Xinran Lin
    Citation: Cardiovascular Diabetology 2023 22:315
  8. Diabetes microangiopathy, a hallmark complication of diabetes, is characterised by structural and functional abnormalities within the intricate network of microvessels beyond well-known and documented target o...

    Authors: Dídac Mauricio, Mònica Gratacòs and Josep Franch-Nadal
    Citation: Cardiovascular Diabetology 2023 22:314
  9. Atherogenic index of plasma (AIP) has been demonstrated as a surrogate marker for ischemic stroke, but there is limited evidence for the effect of long-term elevation of AIP on ischemic stroke. Therefore, we a...

    Authors: Huancong Zheng, Kuangyi Wu, Weiqiang Wu, Guanzhi Chen, Zekai Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:313
  10. Metabolic cardiomyopathy (MCM), characterized by intramyocardial lipid accumulation, drives the progression to heart failure with preserved ejection fraction (HFpEF). Although evidence suggests that the mammal...

    Authors: Sarah Costantino, Alessandro Mengozzi, Srividya Velagapudi, Shafeeq Ahmed Mohammed, Era Gorica, Alexander Akhmedov, Alessia Mongelli, Nicola Riccardo Pugliese, Stefano Masi, Agostino Virdis, Andreas Hülsmeier, Christian Matthias Matter, Thorsten Hornemann, Giovanni Melina, Frank Ruschitzka, Thomas Felix Luscher…
    Citation: Cardiovascular Diabetology 2023 22:312
  11. Prior research has established the correlation between insulin resistance (IR) and hypertension. While the association between triglyceride-glucose (TyG) index, a reliable surrogate marker of IR, and uncontrol...

    Authors: Liao Tan, Yubo Liu, Jie Liu, Guogang Zhang, Zhaoya Liu and Ruizheng Shi
    Citation: Cardiovascular Diabetology 2023 22:311
  12. There is growing evidence that ceramides play a significant role in the onset and progression of non-alcoholic fatty liver disease (NAFLD), a highly prevalent condition in patients with type 2 diabetes associa...

    Authors: Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno Vergès and Jean-Michel Petit
    Citation: Cardiovascular Diabetology 2023 22:310
  13. The triglyceride glucose-body mass (TyG-BMI) index is acknowledged as both a reliable indicator of the risk of cardiovascular disease and an accurate surrogate biomarker for evaluating insulin resistance (IR)....

    Authors: Jiahao Dou, Chen Guo, Yawen Wang, Zihe Peng, Ruiyun Wu, Qiangqiang Li, Hong Zhao, Shoufang Song, Xuelu Sun and Jin Wei
    Citation: Cardiovascular Diabetology 2023 22:309
  14. Previous studies have investigated the association between the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) and the incidence of diabetes in adults and discovered that a high TG/...

    Authors: Hiroki Yuge, Hiroshi Okada, Masahide Hamaguchi, Kazushiro Kurogi, Hiroaki Murata, Masato Ito and Michiaki Fukui
    Citation: Cardiovascular Diabetology 2023 22:308
  15. This study aimed to explore the association between the triglyceride-glucose (TyG) index and the risk of in-hospital mortality in critically ill patients with sepsis.

    Authors: Rui Zheng, Songzan Qian, Yiyi Shi, Chen Lou, Honglei Xu and Jingye Pan
    Citation: Cardiovascular Diabetology 2023 22:307
  16. Gut microbiota imbalances have been suggested as a contributing factor to atrial fibrillation (AF), but the causal relationship is not fully understood.

    Authors: Huajie Dai, Tianzhichao Hou, Qi Wang, Yanan Hou, Zheng Zhu, Yijie Zhu, Zhiyun Zhao, Mian Li, Hong Lin, Shuangyuan Wang, Ruizhi Zheng, Yu Xu, Jieli Lu, Tiange Wang, Guang Ning, Weiqing Wang…
    Citation: Cardiovascular Diabetology 2023 22:306
  17. The triglyceride-glucose (TyG) index has been proposed as a potential predictor of adverse prognosis of coronary heart disease (CHD). However, its prognostic value in patients with CHD and hypertension remains...

    Authors: Shiyi Tao, Lintong Yu, Jun Li, Li Huang, Xuanchun Huang, Wenjie Zhang, Zicong Xie, Yuqing Tan and Deshuang Yang
    Citation: Cardiovascular Diabetology 2023 22:305
  18. Triglyceride-glucose index (TyG) has been widely used to predict cardiovascular outcomes. However, it remains unclear whether TyG holds prognostic significance for patients with coronary chronic total occlusio...

    Authors: Yu Yang, Mengqing Ma, Jian Zhang, Shiyu Jin, Dingxin Zhang and Xianhe Lin
    Citation: Cardiovascular Diabetology 2023 22:304
  19. Diabetic cardiomyopathy (DCM) is a major complication of diabetes and a risk factor for cardiovascular disease. Endothelial dysfunction is central to DCM, and endothelial-to-mesenchymal transition (EndMT) is a...

    Authors: Eric Wang, Shali Chen, Honglin Wang, Tori Chen and Subrata Chakrabarti
    Citation: Cardiovascular Diabetology 2023 22:303
  20. Recent type 2 diabetes guidance from the UK’s National Institute for Health and Care Excellence (NICE) proposes offering SGLT2-inhibitor therapy to people with established atherosclerotic cardiovascular diseas...

    Authors: Katherine G. Young, Rhian Hopkins, Beverley M. Shields, Nicholas J. Thomas, Andrew P. McGovern and John M. Dennis
    Citation: Cardiovascular Diabetology 2023 22:302
  21. Sclerostin is an inhibitor of the Wnt/b-catenin pathway, which regulates bone formation, and can be expressed in vascular smooth muscle cells (VSMCs). Type 2 diabetes (T2D) is associated with an increased risk...

    Authors: Sheila González-Salvatierra, Cristina García-Fontana, Jesus Lacal, Francisco Andújar-Vera, Luis Martínez-Heredia, Raquel Sanabria-de la Torre, María Ferrer-Millán, Enrique Moratalla-Aranda, Manuel Muñoz-Torres and Beatriz García-Fontana
    Citation: Cardiovascular Diabetology 2023 22:301
  22. There is uncertainty regarding the role of obesity in type 1 diabetes development. The aim of this systematic review and meta-analysis was to collect and synthesize evidence regarding BMI and the risk of devel...

    Authors: Maya Nitecki, Hertzel C. Gerstein, Yulia Balmakov, Eyal Tsur, Vladislav Babushkin, Tomer Michaeli, Arnon Afek, Orit Pinhas-Hamiel, Tali Cukierman-Yaffe and Gilad Twig
    Citation: Cardiovascular Diabetology 2023 22:300
  23. Circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) is a marker for heart failure in patients with coronary heart disease (CHD) and associated with glycemic abnormalities. Studies on the associat...

    Authors: Tong Yang, Hongmei Zheng, Guangwei Pan, Ruiying Guo, Fengmin Liu, Shengyuan Liu, Shuang Tao, Lin Li, Rongrong Yang and Chunquan Yu
    Citation: Cardiovascular Diabetology 2023 22:299
  24. Uric acid (UA) is an independent prognostic factor for cardiovascular events, but there are no data demonstrating a different risk profile between women and men. Thus, we tested whether UA is associated with a...

    Authors: Maria Perticone, Raffaele Maio, Ermal Shehaj, Simona Gigliotti, Benedetto Caroleo, Edoardo Suraci, Angela Sciacqua, Francesco Andreozzi and Francesco Perticone
    Citation: Cardiovascular Diabetology 2023 22:298
  25. The study aimed to investigate an association of increased liver fibrosis with acute myocardial infarction (AMI), and to investigate the mediating effect of serum follistatin-like protein 3 (FSTL3) on the asso...

    Authors: Wenfei Duan, Ruixiao Shi, Fang Yang, Zhoujunhao Zhou, Lihong Wang, Zhe Huang and Shufei Zang
    Citation: Cardiovascular Diabetology 2023 22:297
  26. We investigated the association of high-sensitivity cardiac troponin (Hs-cTn) with all-cause and cardiovascular mortality in non-diabetic individuals.

    Authors: Lin Liu, Yuen Ting Cheng, Aimin Xu and Bernard M. Y. Cheung
    Citation: Cardiovascular Diabetology 2023 22:296
  27. The study was designed to assess the effect of co-occurrence of diabetes mellitus (DM) and hypertension on the deterioration of left atrioventricular coupling index (LACI) and left atrial (LA) function in comp...

    Authors: Rui Shi, Yi-Ning Jiang, Wen-Lei Qian, Ying-Kun Guo, Yue Gao, Li-Ting Shen, Li Jiang, Xue-Ming Li, Zhi-Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2023 22:295
  28. The PI3K/AKT pathway transduces the majority of the metabolic actions of insulin. In addition to cytosolic targets, insulin-stimulated phospho-AKT also translocates to mitochondria in the myocardium. Mouse mod...

    Authors: Yu-Han Chen, Albert P. Ta, Yumay Chen, Hsiao-Chen Lee, Wenjun Fan, Phang-Lang Chen, Maria C. Jordan, Kenneth P. Roos, Grant R. MacGregor, Qin Yang, Robert A. Edwards, Junfeng Li and Ping H. Wang
    Citation: Cardiovascular Diabetology 2023 22:294
  29. Diabetic kidney disease (DKD) is characterized by the abnormal deposition of oxidized low-density lipoprotein (ox-LDL), which contributes to podocyte damage. Klotho, an aging suppressor that plays a critical r...

    Authors: Wei Jiang, Chun Gan, Xindi Zhou, Qing Yang, Dan Chen, Han Xiao, Lujun Dai, Yaxi Chen, Mo Wang, Haiping Yang and Qiu Li
    Citation: Cardiovascular Diabetology 2023 22:293
  30. The triglyceride-glucose (TyG) index has been suggested as a dependable indicator for predicting major adverse cardiovascular events (MACE) in individuals with cardiovascular conditions. Nevertheless, there is...

    Authors: Enmin Xie, Zixiang Ye, Yaxin Wu, Xuecheng Zhao, Yike Li, Nan Shen, Yanxiang Gao and Jingang Zheng
    Citation: Cardiovascular Diabetology 2023 22:292
  31. Women with gestational diabetes mellitus (GDM) have higher insulin resistance and/or reduced secretion, an increased risk of future diabetes and cardiovascular disease, which may be due to a pathological activ...

    Authors: Dan Yedu Quansah, Antje Horsch, Leah Gilbert, Marc Y. Donath and Jardena J. Puder
    Citation: Cardiovascular Diabetology 2023 22:291
  32. A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM), heart fa...

    Authors: Jui-Yi Chen, Heng-Chih Pan, Chih-Chung Shiao, Min-Hsiang Chuang, Chun Yin See, Tzu-Hsuan Yeh, Yafei Yang, Wen-Kai Chu and Vin-Cent Wu
    Citation: Cardiovascular Diabetology 2023 22:290
  33. Coronary bifurcation lesion, as a complex coronary lesion, is associated with higher risk of long-term poor prognosis than non-bifurcation lesions. The triglyceride-glucose (TyG) index has been shown to predic...

    Authors: Jining He, Sheng Yuan, Chenxi Song, Yanjun Song, Xiaohui Bian, Guofeng Gao and Kefei Dou
    Citation: Cardiovascular Diabetology 2023 22:289
  34. Various studies have indicated that stress hyperglycemia ratio (SHR) can reflect true acute hyperglycemic status and is associated with poor outcomes in patients with acute coronary syndrome (ACS). However, da...

    Authors: Enmin Xie, Zixiang Ye, Yaxin Wu, Xuecheng Zhao, Yike Li, Nan Shen, Yanxiang Gao and Jingang Zheng
    Citation: Cardiovascular Diabetology 2023 22:288
  35. Although recent guidelines advocate for HbA1c target individualization, a comprehensive criterion for patient categorization remains absent. This study aimed to categorize HbA1c variability levels and explore ...

    Authors: Junyu Pei, Xiaopu Wang, Zeyu Pei and Xinqun Hu
    Citation: Cardiovascular Diabetology 2023 22:287
  36. The triglyceride-glucose (TyG) index, which is a reliable substitute indicator for insulin resistance, has been considered an independent risk factor for long-term outcomes in patients with cardiovascular dise...

    Authors: Shutong Dong, Zehao Zhao, Xin Huang, Meishi Ma, Zhiqiang Yang, Chu Fan, Hongya Han, Zhijian Wang, Dongmei Shi and Yujie Zhou
    Citation: Cardiovascular Diabetology 2023 22:286
  37. The study aimed to assess the usefulness of capillaroscopy and photoplethysmography in the search for early vascular anomalies in children with type 1 diabetes.

    Authors: Klaudia Bogusz-Górna, Adriana Polańska, Aleksandra Dańczak-Pazdrowska, Ryszard Żaba, Marta Sumińska, Piotr Fichna and Andrzej Kędzia
    Citation: Cardiovascular Diabetology 2023 22:285
  38. The Triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, is independently associated with the severity of coronary artery lesions and the prognosis of coronary heart disease. The inve...

    Authors: Qiang Chen, Shiqiang Xiong, Zhen Zhang, Xiuqiong Yu, Yingzhong Chen, Tao Ye, Siqi Yang, Lingyao Qi, Xu Chen, Hanxiong Liu, Jingang Zheng and Lin Cai
    Citation: Cardiovascular Diabetology 2023 22:284
  39. Early diagnosis and treatment effectiveness of early-onset coronary artery disease (EOCAD) are crucial, and non-invasive predictive biomarkers are needed for young adults. We aimed to evaluate the usefulness o...

    Authors: Shalaimaiti Shali, Lingfeng Luo, Kang Yao, Xiangdong Sun, Hongyi Wu, Shuning Zhang, Lili Xu, Wei Gao, Jianxuan Li, Juying Qian, Yan Zheng, Yuxiang Dai and Junbo Ge
    Citation: Cardiovascular Diabetology 2023 22:283
  40. It is unclear to what extent genetics explain the familial clustering and the co-occurrence of distinct cardiometabolic disorders in the general population. We therefore aimed to quantify the familial (co-)agg...

    Authors: Rima D. Triatin, Zekai Chen, Alireza Ani, Rujia Wang, Catharina A. Hartman, Ilja M. Nolte, Chris H. L. Thio and Harold Snieder
    Citation: Cardiovascular Diabetology 2023 22:282
  41. Among patients with acute coronary syndrome and percutaneous coronary intervention, stress hyperglycemia ratio (SHR) is primarily associated with short-term unfavorable outcomes. However, the relationship betw...

    Authors: Jin Liu, Yang Zhou, Haozhang Huang, Rui Liu, Yu Kang, Tingting Zhu, Jielan Wu, Yuwei Gao, Yuqi Li, Chenyang Wang, Shiqun Chen, Nianjin Xie, Xueyan Zheng, Ruilin Meng, Yong Liu, Ning Tan…
    Citation: Cardiovascular Diabetology 2023 22:281
  42. Diabetes mellitus (DM) accelerates the progression of aortic stenosis (AS), but how their underlying molecular mechanisms interact is not clear. Moreover, whether DM contributes to clinically relevant sex-diff...

    Authors: Ernesto Martín-Núñez, Miriam Goñi-Olóriz, Lara Matilla, Mattie Garaikoetxea, Laura Mourino-Alvarez, Adela Navarro, Amaya Fernández-Celis, Ibai Tamayo, Alicia Gainza, Virginia Álvarez, Rafael Sádaba, María G. Barderas, Eva Jover and Natalia López-Andrés
    Citation: Cardiovascular Diabetology 2023 22:280
  43. The association between the triglyceride-glucose (TyG) index and mortality in cardiovascular disease (CVD) patients with diabetes or pre-diabetes remains unclear. This study aimed to investigate the relationsh...

    Authors: Qin Zhang, Shucai Xiao, Xiaojuan Jiao and Yunfeng Shen
    Citation: Cardiovascular Diabetology 2023 22:279
  44. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in reducing the risk of atrial fibrillation (AF). However, the results are controversial and the underlying metabolic mechanism remains uncl...

    Authors: Jiang Li, Yuefeng Yu, Ying Sun, Bowei Yu, Xiao Tan, Bin Wang, Yingli Lu and Ningjian Wang
    Citation: Cardiovascular Diabetology 2023 22:278
  45. In recent years, several novel agents have become available to treat individuals with type 2 diabetes (T2D), such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i), tirzepatide, which is a dual glucose-de...

    Authors: Antonio Ceriello, Helena W. Rodbard, Tadej Battelino, Frank Brosius, Francesco Cosentino, Jennifer Green, Linong Ji, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T. Prashant Nedungadi, Christopher G. Parkin, Lars Rydén, Wayne Huey-Herng Sheu…
    Citation: Cardiovascular Diabetology 2023 22:277
  46. O-GlcNAcylation is the enzymatic addition of a sugar, O-linked β-N-Acetylglucosamine, to the serine and threonine residues of proteins, and is abundant in diabetic conditions. We have previously shown that O-G...

    Authors: Chidinma A Okolo, Ei-Phyo Khaing, Valeria Mereacre, Rachel S Wallace, Michelle L Munro, Jeffrey R Erickson and Peter P. Jones
    Citation: Cardiovascular Diabetology 2023 22:276
  47. The stress hyperglycemia ratio (SHR) has demonstrated a noteworthy association with unfavorable cardiovascular clinical outcomes and heightened in-hospital mortality. Nonetheless, this relationship in critical...

    Authors: Le Li, Minghao Zhao, Zhuxin Zhang, Likun Zhou, Zhenhao Zhang, Yulong Xiong, Zhao Hu and Yan Yao
    Citation: Cardiovascular Diabetology 2023 22:275
  48. Evidence on the associations between baseline stromal cell-derived factor (SDF)-1 and clinical outcomes in acute ischemic stroke patients is lacking. The present study aimed to examine the relationship between...

    Authors: Shoujiang You, Hongyu Chen, Mengyuan Miao, Jigang Du, Bizhong Che, Tan Xu, Chun-Feng Liu, Yonghong Zhang, Jiang He, Xiaoyan Zhong, Yongjun Cao and Chongke Zhong
    Citation: Cardiovascular Diabetology 2023 22:274
  49. This study aimed to reveal the prevalence of sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment and its association with restenosis risk in patients with diabetes mellitus undergoing endovascular ther...

    Authors: Mitsuyoshi Takahara, Yoshimitsu Soga, Masahiko Fujihara, Osamu Iida and Daizo Kawasaki
    Citation: Cardiovascular Diabetology 2023 22:273
  50. Effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) on preventing progressive chronic kidney outcomes is uncertain for type 2 diabetes (T2D) patients requir...

    Authors: Zi-Yang Peng, Chun-Ting Yang, Wei-Hung Lin, Wen-Yu Yao, Huang-Tz Ou and Shihchen Kuo
    Citation: Cardiovascular Diabetology 2023 22:272

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions